The TRICURE First in Human Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

March 1, 2025

Study Completion Date

May 15, 2029

Conditions
Tricuspid Regurgitation
Interventions
DEVICE

Topaz TTVR System

Transcatheter tricuspid heart valve replacement

Trial Locations (11)

1200

Cliniques Universitaires Saint-Luc UCL, Brussels

13008

Hôpital Saint Joseph, Marseille

33000

CHU Bordeaux, Bordeaux

35000

CHU Pontchaillou, Rennes

59037

University Hospital Lille, Institut Cœur Poumon, Lille

69677

Hospices Civils de Lyon, Hôpital Cardiothoracique Louis Pradel, Bron

93200

Centre Cardiologique du Nord, Saint-Denis

94010

CHU Henri Mondor, Créteil

Unknown

Algemeen Stedelijk Ziekenhuis,, Aalst

ZNA Middelheim, Antwerp

Centre hospitalier universitaire CHU de Liège, Liège

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TRiCares

INDUSTRY

NCT05126030 - The TRICURE First in Human Trial | Biotech Hunter | Biotech Hunter